e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tvardi Therapeutics, Inc. - Common Stock
(NQ:
TVRD
)
41.60
-1.38 (-3.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tvardi Therapeutics, Inc. - Common Stock
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
August 21, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
August 14, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 15, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
May 27, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
May 20, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update
May 13, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference
May 06, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.